Clinical Benefit of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors

Thomas A. Zelniker, Eugene Braunwald

2020Journal of the American College of Cardiology104 citationsDOI

Topics & Concepts

MedicineClinical trialFood and drug administrationCanagliflozinDiabetes mellitusIntensive care medicineAdverse effectCotransporterType 2 diabetesType 2 Diabetes MellitusPharmacologyInternal medicineEndocrinologySodiumChemistryOrganic chemistryDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerPancreatic function and diabetes